Abstract: A resonant sensor probe assembly includes a substrate formed from one or more dielectric materials and free-standing electrodes coupled with the substrate. The free-standing electrodes are configured to be placed into the fluid and to generate an electric field between the free-standing electrodes. A controller measures an impedance response of the sensor to the fluid between the electrodes to determine an aging effect of the sensor.

Abstract: The present disclosure provides an air intake system for a power machine that can use a hollow section of a frame of the power machine to form part of an air intake path. The air intake system can include an air inlet coupled to an exterior panel of the power machine, a filter assembly including a filter enclosure and a filter element, a first air conduit coupled between the inlet and an enclosed compartment of a frame of the power machine, and a second air conduit coupled between the enclosed compartment and the filter enclosure. To reach the filter enclosure, the air entering the filter enclosure can travel along an air intake path that includes the air inlet, the first air conduit, the enclosed compartment, and the second air conduit.

Abstract: Applications for a Content Engagement Power (CEP) value include directing live actors during a performance, for experience in a real or virtual theater. The CEP is computed based on biometric sensor data processed to express audience engagement with content along multiple dimensions such as valence, arousal, and dominance. An apparatus is configured to perform the method using hardware, firmware, and/or software.

Abstract: The present invention relates to promoters, enhancers and other regulatory elements that direct expression within SMC, comprising nucleotide sequences from the 5′ regulatory region and the first intron, and transcriptionally active fragments thereof, that control expression of an SM &agr;-A. Specifically provided are expression vectors, host cells and transgenic animals wherein an SM &agr;-A regulatory region is capable of controlling expression of a heterologous gene, over-expressing an endogenous SMC gene or an inhibitor of a pathological process or knocking out expression of a specific gene believed to be important for an SM-related disease in SMC. The invention also relates to methods for using said vectors, cells and animals for screening candidate molecules for agonists and antagonists of disorders involving SMC. The invention further relates to compositions and methods for modulating expression of compounds within SMC, and to screening compounds that modulate expression within SMC.